INHERITED AND ACQUIRED THROMBOTIC RISK FACTORS IN WOMEN WITH A HISTORY OF OBSTETRIC PATHOLOGY


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

Objective: to study the detection rate of genetic polymorphisms associated with thrombophilia, as well as the structure of thrombotic risk factors and the pattern of chronic somatic diseases in women with a history of obstetric complications. Subjects and methods. One hundred and five women whose mean age was 30.5±5.1 years were examined. The inclusion criteria were a history of recurrent miscarriage; more than 1 loss at 10 weeks or more gestational age; early fetal death; severe preeclampsia; placental insufficiency; premature detachment of a normally situated placenta; two unsuccessful IVF attempts or more. The exclusion criteria were fetal chromosomal abnormalities with reproductive loss; a patient’s refusal to participate in the study. The investigators performed clinical examination, molecular genetic testing for Factor V Leiden (FVL), F II G20210A, C677T MTHFR, Fgb 455 G>A, Leu33Pro GP IIb/IIIa, PAI-1 675 5G>4G and determined lupus anticoagulant, IgM and IgG anticardiolipin antibodies, β2-glycoprotein 1 antibodies, and made quantitative assay of antithrombin III activity. Results. Inherited thrombophilias were found in 102 (97%) cases; of them 85% women had mixed thrombophilias. Antiphospholipid antibodies were detected in 23% of patients, their association with polymorphisms to thrombotic diseases being observed in 21% of cases. The rate of the detected antiphospholipid syndrome was 3.8%. Other risk factors were encountered with a high frequency; these were chronic endometritis (51%), overweight and obesity (40%), and use of combination oral contraceptives (44%). More than one third of the women had a combination of a few risk factors and chronic extragenital diseases.

Texto integral

Acesso é fechado

Sobre autores

V. DOLGUSHINA

Chelyabinsk State Medical Academy, Russian Agency for Health Care

Email: vereinank@chelcom.ru

N. VEREINA

Chelyabinsk State Medical Academy, Russian Agency for Health Care

Bibliografia

  1. Айламазян Э.К., Зайнулина М.С. Наследственная тромбофилия: дифференцированный подход к оценке риска акушерских осложнений // Акуш. и гин. — 2010. — № 3. — С. 3—9.
  2. Васильев С. А. Роль наследственности в развитии тромбозов // Тромбоз, гемостаз и реология. — 2007. — № 3. — С. 3—14.
  3. Макацария А.Д., Бицадзе В.О., Акиньшина А.В. Тромбозы и тромбоэмболии в акушерско-гинекологической клинике. Молекулярно-генетические механизмы и стратегия профилактики тромбоэмболических осложнений: Руководство для врачей. — М.: ООО «МИА», 2007.
  4. Профилактика повторных осложнений беременности в условиях тромбофилии (синдром потери плода, гестозы, преждевременная отслойка нормально расположенной плаценты, тромбозы и тромбоэмболии): руководство для врачей / Под ред. А.Д. Макацария. — М.: Триада-Х, 2008.
  5. Сидельникова В.М. Невынашивание беременности — современный взгляд на проблему // Акуш. и гин. — 2007. — № 5. — С. 24—27.
  6. Brenner B. Thrombophilia in pregnancy and its role in abortion // Womens Health. — 2005. — Vol. 1, № 1. — P. 35—38.
  7. Kujovich J.L. Thrombophilia and pregnancy complications // Am. J. Obstet. Gynecol. — 2004. — Vol. 191. — P. 412— 424.
  8. Rosendaal F.R., Doggen C. J., Zivelin M. et al. Geografic distribution of the 20210 G to A prothrombin variant // J. Thromb. Haemost. — 1998. — Vol. 79. — P. 706—708.
  9. Stein P.D., Hull R.D., Kayali F. et al. Venous thromboembolism inpregnancy: 21-yeartrends // Am. J. Med. —2004. —Vol. 117. — P. 121—125.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Bionika Media, 2011

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies